Cetus Oncology Corp.

Once seen as the next big thing in cancer, cytokine-based therapies lost their shine after numerous trial flops, but Synthekine is among a number of companies that believe they can succeed with a ne

Amgen Inc. and Onyx Pharmaceuticals Inc. ended weeks of merger negotiations and market speculation Aug. 25 with an announcement that they had reached an agreement for Amgen to acquire the cancer

When Illumina Inc. chairman William Rastetter, PhD, got a call from Arthur Levinson, PhD, a Roche director, in November, it was ostensibly to discuss a Roche equity investment in Illumina and